News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Policy
Approving Sarepta’s DMD Drug Could Force FDA To Get Creative
May 26, 2016
·
1 min read
Policy
Sarepta Rockets After the FDA Delays Ruling on DMD Drug
May 25, 2016
·
4 min read
Bio NC
Sarepta Who? This DMD Drugmaker Might be a Better Buy for Investors
May 20, 2016
·
3 min read
FDA
Betting Intensifies Over Sarepta’s DMD Drug
May 6, 2016
·
1 min read
Deals
As Sarepta And Valeant Exit Hearings, Biotech Steps Into M&A
May 3, 2016
·
1 min read
Policy
Rounding Up the Experts’ Thoughts on What’s Next for Sarepta’s DMD Drug
April 27, 2016
·
3 min read
Policy
FDA Panel’s 7-6 Vote Against Sarepta’s DMD Drug Underlines Battle Between Science and Patient Advocates
April 26, 2016
·
5 min read
Policy
Sarepta’s Stock a Rollercoast Ride Prior to Today’s FDA Hearing
April 25, 2016
·
3 min read
FDA
Sarepta Craters as the FDA Releases Documents Ahead of Monday’s DMD Drug Hearing
April 21, 2016
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2026
July 1, 2026
·
1 min read
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
·
17 min read
Press Releases
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
June 2, 2026
·
1 min read
Press Releases
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 14, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
May 7, 2026
·
19 min read
Press Releases
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
April 23, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
April 1, 2026
·
1 min read
Press Releases
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
9 min read
Press Releases
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
1 min read
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
·
15 min read
